Novel depots of ketorolac esters have long-acting antinociceptive and antiinflammatory effects

Anesthesia and Analgesia

Volumn 101, Issue 3, 2005, Pages 785-792

  Liu, Shyun Yeu ^a,b,c   Shieh, Ja Ping ^c   Tzeng, Jann Inn ^c   Hou, Chia Hui ^c   Cheng, Yen Ling ^c   Huang, Kuo Lun ^c   Wang, Jhi Joung ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC; KETOROLAC DECYL ESTER; KETOROLAC HEPTYL ESTER; KETOROLAC PENTYL ESTER; KETOROLAC PROPYL ESTER; KETOROLAC TROMETAMOL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; RAT;

EID: 23944481904     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000166978.12457.7a     Document Type: Article

References (24)

1. Viscusi ER, Reynolds L, Chung F, et al. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA 2004;291:1333-41.
2. Reinhart DJ, Goldberg ME, Roth JV, et al. Transdermal fentanyl system plus im ketorolac for the treatment of postoperative pain. Can J Anaesth 1997;44:377-84.
3. Chu KS, Wang JJ, Hu OYP, et al. The antinociceptive effect of nalbuphine and its long-acting esters in rats. Anesth Analg 2003;97:806-9.
4. Smith LA, Carroll D, Edwards JE, et al. Single-dose ketorolac and pethidine in acute postoperative pain: systematic review with meta-analysis. Br J Anaesth 2000;84:48-58.
5. Anthony D, Jasinski DM. Postoperative pain management: morphine versus ketorolac. J Pediatr Nurs 2002;17:30-42.
6. Forrest JB, Heitlinger EL, Revell S. Ketorolac for postoperative pain management in children. Drug Saf 1997;16:309-29.
7. Buckley MMT, Brogden RN. Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990;39:86-109.
8. Munro HM, Walton SR, Malviya S, et al. Low-dose ketorolac improves analgesia and reduces morphine requirements following posterior spinal fusion in adolescents. Can J Anaesth 2002; 49:461-6.
9. Zhou TJ, Tang J, White PF. Propacetamol versus ketorolac for treatment of acute postoperative pain after total hip or knee replacement. Anesth Analg 2001;92:1569-75.
10. Pavy TJG, Paech MJ, Evans SF. The effect of intravenous ketorolac on opioid requirement and pain after Cesarean delivery. Anesth Analg 2001;92:1010-41.
11. Allen LVJ, Popovich NG, Ansel HC. Dosage form design: biopharmaceutic and pharmacokinetics considerations. In: Ansel's pharmaceutical dosage forms and drug delivery systems. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:142-85.
12. Allen LVJ, Popovich NG, Ansel HC. Solid oral modified-release dosage forms and drug delivery system. In: Ansel's pharmaceutical dosage forms and drug delivery systems. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2005: 260-75.
13. Allen LVJ, Popovich NG, Ansel HC. Parenterals. In: Ansel's pharmaceutical dosage forms and drug delivery systems. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:443-505.
14. Beresford R, Ward A. Haloperidol decanoate: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. Drugs 1987;33:31-49.
15. Doh HJ, Cho WJ, Yong CS, et al. Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. J Pharm Sci 2003;92:1008-17.
16. Fletcher D, Le Corre P, Guilbaud G, Le Verge R. Antinociceptive effect of bupivacaine encapsulated in poly(D, L)-lactide-coglycolide microspheres in the acute inflammatory pain model of carrageenin-injected rats. Anesth Analg 1997;84:90-4.
17. Kayser V, Guilbaud G. Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain 1987;28:99-107.
18. Fletcher D, Kayser V, Guilbaud G. Influence of timing of administration on the analgesic effect of bupivacaine infiltration in carrageenin-injected rats. Anesthesiology 1996;84:1129-37.
19. O'Neill MF, Dourish CT, Iversen SD. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329. Neuropharmacology 1989;28:243-7.
20. Norman PH, Daley MD, Lindsey RW. Preemptive analgesic effects of ketorolac in ankle fracture surgery. Anesthesiology 2001;94:599-603.
21. Ashworth HL, Ong C, Seed PT, Venn PJ. The influence of timing and route of administration of intravenous ketorolac on analgesia after hand surgery. Anaesthesia 2002;57:535-9.
22. Alexander R, El-Moalem HE, Gan TJ. Comparison of the morphine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery. J Clin Anesth 2002;14:187-92.
23. Carney DE, Nicolette LA, Ratner MH, et al. Ketorolac reduces postoperative narcotic requirement. J Pediatr Surg 2001;36:76-9.
24. Testa B, Mayer JM. Introduction: metabolic hydrolysis and prodrug design. In: Hydrolysis in drug and prodrug metabolism: chemistry, biochemistry, and enzymology. Zürich, Switzerland: Verlag Helvetica Chimica Acta, 2003:1-11.